🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 54303L104
- Market Cap
- Small Cap
- IPO
- 2/12/2021 · $10.00/share
Business: Longeveron Inc. is a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. Longeveron’s mission is to provide biological solutions for aging-related diseases and life-threatening conditions, and is dedicated to developing safe and effective cell-based therapeutics for unmet medical needs such as Aging Frailty, the Metabolic Syndrome, Alzheimer’s Disease and congenital heart defects in children.
Company Contact
- CEO
- Wa’el Hashad
- CFO
- Lisa Locklear
- Headquarters
- 1951 NW 7th Avenue, Suite 520, Miami, FL 33136
- Phone
- 305-909-0840 · Toll-Free 844-470-2550
- Investor Relations
- Derek Cole, Advisory Solutions · derek.cole@iradvisory.com